Metier Executives’ Post

What is Senhance Surgical Robotics? Senhance Surgical Robotics, developed by Asensus Surgical now owned by KARL STORZ is transforming the future of minimally invasive surgery. Designed to give surgeons greater control while integrating cutting-edge technologies, Senhance combines the precision of robotics with the efficiency of digital laparoscopy. With features like haptic feedback, eye-tracking camera control, and reusable instruments, the system offers a unique blend of innovation and cost-effectiveness that sets it apart from traditional robotic platforms. The technology behind Senhance is focused on enhancing surgeon capabilities while reducing costs. Its haptic feedback provides a sense of touch during surgery, a critical feature for precision. Additionally, eye-tracking camera control allows for hands-free vision adjustment, boosting operational efficiency. With digital laparoscopy and 3D high-definition vision, surgeons experience enhanced depth perception and accuracy in every procedure. Senhance is not only about better technology, but it’s also about improving patient outcomes and making robotic surgery more accessible. By providing a cost-effective solution with reusable instruments and scalable capabilities, it empowers hospitals to adopt advanced surgical robotics without excessive costs. Senhance is redefining the standards of robotic-assisted surgery, paving the way for more efficient and precise operations. #surgicalrobotics #medtech

To view or add a comment, sign in

Explore topics